Recruiting Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma NCT06498648 Conditions Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, Advanced Soft Tissue Sarcoma, +13 more Locations UT MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
Active, Not Recruiting Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma NCT05694871 Conditions Advanced Dedifferentiated Liposarcoma, Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, +9 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Cancer Center at Saint Joseph's — Phoenix, Arizona, United States Mayo Clinic Hospital in Arizona — Phoenix, Arizona, United States Mayo Clinic in Arizona — Scottsdale, Arizona, United States View all 194 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma NCT04967521 Conditions Advanced Dedifferentiated Liposarcoma Locations University of Colorado Cancer Center, Anschutz Medical Campus — Aurora, Colorado, United States Mayo Clinic Florida — Jacksonville, Florida, United States Northwestern University — Chicago, Illinois, United States Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
